Xenetic Biosciences (XBIO) Non Operating Interest Expenses (2011 - 2017)

Xenetic Biosciences (XBIO) has reported Non Operating Interest Expenses for 7 consecutive years, with $349.0 the latest figure, recorded in Q4 2017.

• For the quarter ending Q4 2017, Non Operating Interest Expenses fell 99.12% year-over-year to $349.0; the trailing twelve-month figure through Dec 2017 stood at $1818.0 (down 99.75% YoY), and the FY2017 full-year result was $1818.0, down 99.75% from the prior year.
• Non Operating Interest Expenses retreated to $349.0 in Q4 2017 per XBIO's latest filing, from $425.0 in the prior quarter.
• Across five years, Non Operating Interest Expenses topped out at $459968.0 in Q1 2015 and bottomed at -$423001.0 in Q4 2015.
• Historically, Non Operating Interest Expenses has averaged $46849.1 across 5 years, with a median of $1137.0 in 2014.
• The widest YoY moves for Non Operating Interest Expenses: up 51932.58% in 2015, down 37303.25% in 2015.
• Over 5 years, Non Operating Interest Expenses stood at -$5695.0 in 2013, then jumped by 119.96% to $1137.0 in 2014, then plunged by 37303.25% to -$423001.0 in 2015, then surged by 109.33% to $39454.0 in 2016, then tumbled by 99.12% to $349.0 in 2017.
• According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $349.0, $425.0, and $456.0 for Q4 2017, Q3 2017, and Q2 2017 respectively.